Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

JAK inhibitors effectively treat inflammatory skin diseases by targeting specific cytokine signals.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

A new compound shows promise as a topical treatment for hair loss.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Baricitinib is a promising treatment for alopecia areata.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Computational methods help design drugs targeting prostate cancer proteins.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.